Carlos Rubio Terrés

Bachelor Biological Sciences (University Autónoma of Madrid), Master Pharmacology (University of Barcelona), Master Pharmacoeconomics (National School of Public Health, Madrid).

Since 2.003: Director, HEALTH VALUE (formerly Hero Consulting). Health Economics & Research of outcomes consulting. Madrid.

Formerly:
1.979-1986: Technical Advisor, Pharmacobiology National Centre. Instituto de Salud Carlos III. Majadahonda (Madrid).
1.987-1.989: Technical Advisor, Drug Evaluation Unit, Ministry of Health. Madrid.
1.987-1.989: Member of Committee for Proprietary Medicinal Products (CPMP) on behalf of the Spanish Ministry of Health. Brussels.
1.990-1.994: Regulatory Affairs Manager. Lederle Laboratories. Madrid.
1.995-1.998: Pharmacoeconomics Manager. Wyeth-Lederle Laboratories. Madrid.
1.999: Director, Farmacoeconomía y Outcomes Research. Madrid.
2.000-2.002: Pharmacoeconomics Manager. Aventis Pharma. Madrid.

158 publications (books & articles) on pharmacoeconomics, meta-analysis, decision analysis, regulatory affairs, clinical trials, statistical design of health research, pharmacology and toxicology.

81 conferences, communications and posters in congress & meetings.

Referee for Medicina Clínica, Gaceta Sanitaria, Lung Cancer (Elsevier), Clinical Drug Investigation (Adis International), Expert Review of Pharmacoeconomics & Outcomes Research (Future Drugs Ltd) and Value in Health (ISPOR).

Member of Editorial Committee of Pharmacoeconomics, Spanish Research Articles (Adis International).

Member of ISPOR Speaker´s Bureau (International Society for Pharmacoeconomics and Outcomes Research).